Clearmind Biomedical


Established in 2014, ClearMind was created with backing from Y Combinator, one of the largest venture capital funds in the US. The founders of ClearMind were members of the Stanford-Taiwan Biomedical Fellowship Program, where they were inspired to build their company.
About Clearmind Biomedical
The ClearMind vision is to save lives and help patients recover from otherwise debilitating brain injuries.

"One Doctor, One Hour" was the objective driving the ClearMind founders to create the Axonpen System. Meeting this objective allows a single surgeon to complete some critical surgeries in one hour, even at small-scale regional hospitals. More importantly, access to faster neurosurgical interventions after suffering a hemorrhagic stroke or other fluid producing injury has the potential to improve patient outcomes, including survival.
Care Area Served
Country(s)
iconicon